Showing results (2461-2470 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|July 7, 2023
The challenges in the monitoring of infectious diseases after the earthquake in Türkiye in 2023Önder Ergönül, Şiran Keske, Apolina Ksinzik, et al.
The Lancet. Infectious Diseases|July 6, 2023
A patient with secondary syphilis following incomplete treatment of primary infectionZachary Lorenz, Lauren Rybolt, Khalil G Ghanem, et al.
The Lancet. Infectious Diseases|June 23, 2023
Super-spreaders: a historical reviewAmir Teicher
The Lancet. Infectious Diseases|June 19, 2023
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak responseShamez N Ladhani, Alexander C Dowell, Scott Jones, et al.
The Lancet. Infectious Diseases|June 25, 2023
Trends in invasive Haemophilus influenzae serotype a disease in England from 2008-09 to 2021-22: a prospective national surveillance studyMarta Bertran, Joshua C D'Aeth, Erjola Hani, et al.
The Lancet. Infectious Diseases|June 8, 2023
How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?Kamini Walia, Marc Mendelson, Gagandeep Kang, et al.
The Lancet. Infectious Diseases|January 27, 2019
Serocorrelates of protection against infant group B streptococcus diseaseKirsty Le Doare, Beate Kampmann, Johan Vekemans, et al.
The Lancet. Infectious Diseases|December 5, 2018
Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysisJoris Hemelaar, Ramyiadarsini Elangovan, Jason Yun, et al.
The Lancet. Infectious Diseases|February 9, 2019
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trialMichael Aboud, Richard Kaplan, Johannes Lombaard, et al.
The Lancet. Infectious Diseases|September 11, 2020
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitalsSameer S Kadri, Yi Ling Lai, Sarah Warner, et al.
Pageof 270